DaVita Inc. (DVA) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
DaVita Inc. (DVA) surged +5.10% to $193.31 as options desks priced 66% call premium vs. 34% put protection around the $189 max-pain magnet. Solid 41% profit margin (29% return on capital), mixed timing at 11x P/E—hold if owned, no rush to chase.
Dialysis provider DaVita Inc. (NYSE:DVA) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 4.6% year on year to $3.58 billion. Its non-GAAP profit of $3.82 per share was 6.9% above analy
DefenCath is CorMedix’s largest revenue driver in the dialysis setting, generating $258.8 million in net sales in 2025 and accounting for a majority of the company's reported full-year revenue of $311.7 million.
S&P 500 unusual-volume screen for Oct. 30, 2026: Reddit fell 30.15% on heavy volume, Global Payments rose 10.41%, and several other stocks traded above average.
IKC outperformance helped offset tech investment drag in Q3.
DVA's Q3 earnings surge 52.2% as revenues rise 4.6%, fueled by strong kidney care and international growth despite rising costs and margin pressure.
Moby summary of DaVita Inc.'s Q3 2026 earnings call
DaVita (NYSE:DVA) reported third-quarter adjusted operating income of $561 million, adjusted earnings per share of $3.82 and free cash flow of $276 million, while narrowing its full-year 2026 outlook. The kidney-care pro
S&P 500 after-hours movers: Mondelez International and FedEx Freight were among gainers, while Intel and Reddit were among decliners after today's U.S. session.
DaVita Q3 2026 EPS beat consensus, revenue was in line, but DVA fell nearly 10% after hours despite recent momentum, raising questions on margins.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on DVA today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for DVA. Explore sector supply chains on /butterfly.
Why DVA Stock surged +5.10% Today — RQD Quant Desk Flash. Solid 41% profit margin (29% return on capital), mixed timing at 11x P/E—hold if owned, no rush to chase.